Letter: Rethinking the lower incidence of HCC in HIV-infected patients- A closer look at confounding factors
- PMID: 37831527
- DOI: 10.1111/apt.17689
Letter: Rethinking the lower incidence of HCC in HIV-infected patients- A closer look at confounding factors
Comment on
-
Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection.Aliment Pharmacol Ther. 2023 Oct;58(8):814-823. doi: 10.1111/apt.17654. Epub 2023 Jul 28. Aliment Pharmacol Ther. 2023. PMID: 37515399
References
REFERENCES
-
- Lui GC, Hui VW, Sze SF, Wong BC, Cheung C, Lee MP, et al. Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection. Aliment Pharmacol Ther. 2023;58:814-823.
-
- Negri F, Missale G, Antoni AD, Porta C. Hepatocellular cancer therapy in patients with HIV infection: disparities in cancer care, trials enrolment, and cancer-related research. Transl Oncol. 2021;14:101153.
-
- Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425-432.
-
- Puoti M, Bruno R, Soriano V, Donato F, Gaeta GB, Quinzan GP, et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. Aids. 2004;18:2285-2293.
-
- Joshi D, O'Grady J, Dieterich D, Gazzard B, Agarwal K. Increasing burden of liver disease in patients with HIV infection. Lancet. 2011;377:1198-1209.
Publication types
MeSH terms
LinkOut - more resources
Medical